Dr Khalid El Bairi is the Founder of The Cancer Biomarkers Working Group, and he is currently pursuing his medical studies at the Faculty of Medicine and Pharmacy of Oujda, Morocco, with a particular interest in Oncology.
He has Published many Peer-Reviewed Articles in the field of predictive and prognostic cancer biomarkers to improve survival outcomes in several WoS and Medline-indexed Journals.
Dr El Bairi's Research focuses particularly on biomarkers for gynecological cancers such as ovarian cancer. He is currently a Member of the Board of various international Scientific Societies, and an Editor and Reviewer for more than 35 Journals including BMC Cancer, PLOS ONE, and Frontiers in Oncology.
Dr El Bairi is also very interested in Teaching evidence-based medicine, clinical research methods, and Publishing ethics to medical and PhD students. He is known for his rough fight against the emergence of predatory journals in African countries.
